However, many treatments for CMT patients have still been studied, and drug therapies, including ascorbic acid, progesterone antagonists and modulators, PXT3003, HDAC6 inhibitors, P2X7 receptor modulators, and cytokines, have been reported [1,7,8,9]. The gene discussed is HDAC6; the disease is Charcot-Marie-Tooth disease.